Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer’s disease: a prospective, observational study of factors affecting survival time from admission to death. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.